Open access peer-reviewed chapter

Recent Advances in the Research and Development of Alpha-1 Proteinase Inhibitor for Therapeutic Use

By Elena Karnaukhova

Submitted: April 11th 2011Reviewed: August 16th 2011Published: March 2nd 2012

DOI: 10.5772/32547

Downloaded: 1864

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Elena Karnaukhova (March 2nd 2012). Recent Advances in the Research and Development of Alpha-1 Proteinase Inhibitor for Therapeutic Use, Lung Diseases Elvis Malcolm Irusen, IntechOpen, DOI: 10.5772/32547. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/lung-diseases-selected-state-of-the-art-reviews/recent-advances-in-the-research-and-development-of-alpha-1-proteinase-inhibitor-for-therapeutic-use" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1864total chapter downloads

3Crossref citations

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Mechanisms Promoting Chronic Lung Diseases: Will Targeting Stromal Cells Cure COPD and IPF?

By Lynne A. Murray and Cory M. Hogaboam

Related Book

First chapter

The Prognosis of Cystic Fibrosis - A Clinician's Perspective

By Patrick Lebecque

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us